Kami Kim – Sanford Guide

Kami Kim, M.D.

Professor of Internal Medicine, Division of Infectious Diseases and International Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida (2017-Present).
Professor of Medicine, Immunology/Microbiology and Pathology, Albert Einstein College of Medicine, Bronx, New York (2002-2017)
Director of the NIH-funded Training Program in Geographic Medicine and Emerging Infections, Albert Einstein College of Medicine, Bronx, New York (2013-2017)

Area of Special Interest

Pathogenesis of toxoplasmosis and malaria, parasitic diseases of global significance. Working with clinical investigators at the Blantyre Malaria Project in Malawi to understand the clinical impact of HIV co-infection upon cerebral malaria.

Professional Recognitions & Appointments

Recipient the National Institute of Allergy and Infectious Disease (NIH-NIAID) National Research Service Award, 1989-1992
1993-1996 Recipient of the NIH-NIAID Clinical Investigator Award (K08)
1997-2002 Recipient of the National Institutes of Health (NIH-NIAID) Independent Scientist Award (K02)
1998-2002 Recipient of the Burroughs Wellcome Fund New Investigator Award in Molecular Parasitology
2001-2003 Burroughs Wellcome Fund New Initiatives in Malaria Research Award
Elected Member, American Society for Clinical Investigation and Association of American Physicians
Fellow, Infectious Diseases Society of America and American Academy of Microbiology

Publication Highlights

Published over 100 articles in peer reviewed journals including:

Rapid Diagnostic Testing of Hospitalized Malawian Children Reveals Opportunities for Improved HIV Diagnosis and Treatment. American Journal of Tropical Medicine and Hygiene - December 2017.
Linking EPCR-binding PfEMP-1 to brain swelling in pediatric cerebral malaria. Cell Host & Microbe - October 2017.
Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes. Nature Communications – January 2016
ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria. Antimicrobial Agents and Chemotherapy – September 2015
Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy. American Journal of Tropical Medicine and Hygiene – June 2015

Education

Harvard University (A.B. Magna Cum Laude)
Columbia College of Physicians and Surgeons (Medical School)
Columbia Presbyterian Medical Center (Residency)
University of California San Francisco (Fellowship –Division of Infectious Diseases)
San Francisco General Hospital, UCSF (Post Doctoral Fellowship – Parasitology Laboratory)
Stanford University School of Medicine (Post Doctoral Fellowship - Department of Microbiology & Immunology)

Disclosures